Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Euro Broadcast News.
Press releases published on July 21, 2025
ETH Welcomes Whale Investments as GoldenMining Launches $7,700 Daily Yield Contract
GlobeNewswire
·
July 21, 2025
New York, US, July 21, 2025 (GLOBE NEWSWIRE) -- GoldenMining is proud to announce the official launch of its new suite of ETH-based income contracts, designed to offer stable, daily returns for investors as Ethereum whale activity continues to surge. With …
ECARX Receives Three ISO Certifications, Further Streamlining Integration with Global Automakers
GlobeNewswire
·
July 21, 2025
SHANGHAI, July 21, 2025 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility technology provider, today announced that it has received ISO9001 (Quality Management Systems), ISO14001 (Environmental Management …
UroGen Announces Five-Year Long-Term Extension Study of the OPTIMA II Trial Demonstrates Long-Term Durability of Response to ZUSDURI™ in Patients with Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
GlobeNewswire
·
July 21, 2025
Findings published in the journal of Clinical Genitourinary Cancer show patients remained event-free for a median of two years after achieving complete response with ZUSDURI (mitomycin) intravesical solution. Among the 17 patients who achieved complete …
Ardelyx to Report Second Quarter 2025 Financial Results on August 4, 2025
GlobeNewswire
·
July 21, 2025
WALTHAM, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …
Expanding Analyst Interest in ORYZON
GlobeNewswire
·
July 21, 2025
MADRID and CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, Ticker: ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics, today announced that Maxim LLC, a U.S.-based …
Skyharbour Partner Company Terra Clean Energy Announces Immediate Follow-Up Summer Drill Program on the Back of Drill Results from Winter Program at South Falcon East Uranium Project
GlobeNewswire
·
July 21, 2025
Vancouver, BC, July 21, 2025 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (“Skyharbour” or the “Company”) is pleased to report that its partner company Terra Clean Energy Corp. (“Terra”, previously Tisdale …
Skyharbour Partner Company Terra Clean Energy Announces Immediate Follow-Up Summer Drill Program on the Back of Drill Results from Winter Program at South Falcon East Uranium Project
GlobeNewswire
·
July 21, 2025
Vancouver, BC, July 21, 2025 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (“Skyharbour” or the “Company”) is pleased to report that its partner company Terra Clean Energy Corp. (“Terra”, previously Tisdale …
Orb Strategies Unveils New Website & Expanded Financial Services
GlobeNewswire
·
July 21, 2025
Zurich, Switzerland, July 21, 2025 (GLOBE NEWSWIRE) -- Orb Strategies, the latest name in financial and FinTech consulting, has launched its new website featuring a suite of updated financial services that is more comprehensive than ever. This enhanced …
Amneal Announces Proposed Refinancing of Existing Credit Agreement, including Private Offering of Senior Secured Notes Due 2032
GlobeNewswire
·
July 21, 2025
BRIDGEWATER, N.J., July 21, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal”) (Nasdaq: AMRX) announced that its subsidiary, Amneal Pharmaceuticals LLC (the “Issuer”), is seeking to borrow $1.800 billion aggregate principal amount of new …
Amneal Reports Certain Preliminary Second Quarter 2025 Financial Results
GlobeNewswire
·
July 21, 2025
– Results Reflect Continued Financial Strength and Deleveraging – BRIDGEWATER, N.J., July 21, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced certain unaudited preliminary financial results …
XRP price rises, CJB Crypto one-day mining contract becomes more popular
GlobeNewswire
·
July 21, 2025
London, UK, July 21, 2025 (GLOBE NEWSWIRE) -- With the rising prices of mainstream cryptocurrencies such as XRP, ETH and BTC, CJB Crypto has attracted more and more users. In order to meet the needs of users to obtain passive income from digital assets …
Stallion Uranium Refines Coyote Target with Highly Conductive Anomalies from Ground EM Survey
GlobeNewswire
·
July 21, 2025
VANCOUVER, British Columbia, July 21, 2025 (GLOBE NEWSWIRE) -- Stallion Uranium Corp. (the “Company” or “Stallion”) (TSX-V: STUD; OTCQB: STLNF; FSE: FE0) is pleased to announce the results from a Stepwise Moving Loop, Time Domain Electromagnetic (“SWML- …
Proposed Consolidation of Shares
GlobeNewswire
·
July 21, 2025
Vancouver, British Columbia, July 21, 2025 (GLOBE NEWSWIRE) -- First American Uranium Inc. (CSE: URM) (FSE: IOR) (OTCPK: FAUMF) (the “Company”) announces that the Company intends to consolidate the common shares in the capital of the Company (the “Shares”) …
Domestic Metals Begins Trading on OTCQB
GlobeNewswire
·
July 21, 2025
VANCOUVER, British Columbia, July 21, 2025 (GLOBE NEWSWIRE) -- Domestic Metals Corp. (the “Company” or “Domestic”) - (TSXV: DMCU; OTCQB: DMCUF; FSE: 03E) announces that its common shares have started trading on the OTCQB marketplace, a U.S. marketplace …
ImCheck’s Announces EMA Orphan Drug Designation for ICT01 as Treatment for Acute Myeloid Leukemia
GlobeNewswire
·
July 21, 2025
ImCheck’s Announces EMA Orphan Drug Designation for ICT01 as Treatment for Acute Myeloid Leukemia Following the FDA ODD, European designation underscores ICT01’s potential as a novel immunotherapy approach in AML Marseille, France, July 21, 2025 – ImCheck …
National Comprehensive Cancer Network® (NCCN®) Guidelines Recommend Monoclonal Antibodies for COVID-19 Prevention in People with Cancer; New Data Published in JAMA Oncology Underscore Severe Impact of COVID-19 on This Population
GlobeNewswire
·
July 21, 2025
NCCN Clinical Practice Guidelines in Oncology for the Prevention and Treatment of Cancer-Related Infections now recommend monoclonal antibodies for pre-exposure prophylaxis against COVID-19 in appropriate cancer populations Reflects growing alignment among …
NodThera Announces Appointment of Dr. Jyothis George as Chief Medical Officer
GlobeNewswire
·
July 21, 2025
NodThera Announces Appointment of Dr. Jyothis George as Chief Medical Officer Former Amgen, Novo Nordisk and Boehringer Ingelheim senior leader joins NodThera Leadership Team Will spearhead clinical advancement of the company’s innovative NLRP3 …
Changes in Nokia Corporation's own shares
GlobeNewswire
·
July 21, 2025
Nokia Corporation Stock Exchange Release 21 July 2025 at 14:00 EEST Changes in Nokia Corporation's own shares Espoo, Finland – A total of 11 148 Nokia shares (NOKIA) held by the company were transferred today without consideration to participants of Nokia' …
George Medicines signs exclusive licensing agreement with Azurity Pharmaceuticals to commercialize WIDAPLIK™ (telmisartan, amlodipine and indapamide) tablets in the US
GlobeNewswire
·
July 21, 2025
George Medicines signs exclusive licensing agreement with Azurity Pharmaceuticals to commercialize WIDAPLIK™ (telmisartan, amlodipine and indapamide) tablets in the US An innovative single pill combination of three medicines, including two doses that are …
Muutokset Nokia Oyj:n omien osakkeiden omistuksessa
GlobeNewswire
·
July 21, 2025
Nokia Oyj Pörssitiedote 21.7.2025 klo 14.00 Muutokset Nokia Oyj:n omien osakkeiden omistuksessa Espoo – Nokia on tänään luovuttanut 11 148 yhtiön hallussa ollutta Nokian osaketta (NOKIA) vastikkeetta suorituksena Nokian osakepohjaisiin kannustinohjelmiin …